LISINOPRIL

Product NDC
71610-727
11-digit product format
716100727
Labeler code
71610
Product ID
71610-727_471f70ee-df85-0cf8-e063-6294a90ad68f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
LISINOPRIL
Dosage form
TABLET
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA076102
Marketing category
ANDA
Marketing start
2023-04-07
Substance
LISINOPRIL
Active strength
40 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
E7199S1YWRLISINOPRIL83915-83-7LISINOPRIL

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71610-727-307161007273030 TABLET in 1 BOTTLE (71610-727-30) 30 tablet2023-09-08NoNoHistorical
71610-727-457161007274545 TABLET in 1 BOTTLE (71610-727-45) 45 tablet2023-08-22NoNoHistorical
71610-727-607161007276090 TABLET in 1 BOTTLE (71610-727-60) 90 tablet2023-08-22NoNoHistorical
71610-727-8071610072780180 TABLET in 1 BOTTLE (71610-727-80) 180 tablet2025-12-29NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
LISINOPRILAphena Pharma Solutions - Tennessee, LLC2025-12-29HUMAN PRESCRIPTION DRUG LABEL4